Disc Medicine, Inc. (NASDAQ:IRON) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jean George Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Jun 7, 2018 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 22, 2020 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past) | Director · Feb 5, 2021 – Feb 5, 2021 · Past |
| Jason Rhodes Other companies: Dyne Therapeutics, Inc. (Chairman · Since at least Sep 16, 2020); Generation Bio Co (Director · Since at least Jun 11, 2020); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past); Epizyme Inc (President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past) | Director · Feb 5, 2021 – Oct 4, 2021 · Past |
| Brian Piekos Other companies: KalVista Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Sep 9, 2024); Elicio Therapeutics, Inc. (Chief Financial Officer · Jun 1, 2023 – Feb 1, 2024 · Past); AMAG Pharmaceuticals Inc (Chief Financial Officer · Jun 9, 2020 – Nov 16, 2020 · Past) | CFO · Feb 12, 2021 – May 31, 2022 · Past |
| Jean Franchi Other companies: Biodesix, Inc. (Director · Since at least Oct 27, 2020); Replimune Group, Inc. (Chief Financial Officer · Dec 9, 2019 – May 16, 2023 · Past); Merrimack Pharmaceuticals Inc (Chief Financial Officer · Feb 15, 2018 – Dec 11, 2018 · Past) | Chief Financial Officer · Since at least Feb 7, 2024 |
| Nadim Ahmed Other companies: Cullinan Therapeutics, Inc. (President and Chief Executive Officer · Since at least Oct 18, 2021); Bristol-Myers Squibb Company (EVP and President, Hematology · Nov 20, 2019 – Dec 31, 2020 · Past); Celgene Corporation (PRES., GLOBAL HEM. AND ONC. · Jun 13, 2018 – Nov 20, 2019 · Past) | Director · Since at least Jul 14, 2025 |
| Donald William Nicholson Other companies: Generation Bio Co (Director · Since at least Jan 11, 2021); Kymera Therapeutics, Inc. (Director · Jun 16, 2021 – Jun 15, 2022 · Past) | Director · Since at least Dec 29, 2022 |
| Georges Gemayel Other companies: Supernus Pharmaceuticals, Inc. (INDEPENDENT NON-EXECUTIVE DIRECTOR · Since at least Feb 21, 2020); Momenta Pharmaceuticals Inc (Director · Jun 19, 2019 – Oct 1, 2020 · Past) | Director · Since at least Apr 29, 2021 |
| Gregg Beloff Other companies: Pandion Therapeutics Inc (See Remarks · Jul 16, 2020 – Apr 1, 2021 · Past); Synlogic Inc (See Remarks · Oct 21, 2019 – Dec 6, 2021 · Past) | Chief Financial Officer · Feb 5, 2021 – Feb 5, 2021 · Past |
| John Quisel Other companies: Gossamer Bio, Inc. (Director · Since at least Nov 28, 2023); Acceleron Pharma Inc (EVP, Chief Business Officer · Sep 18, 2013 – Jan 2, 2020 · Past) | Chief Executive Officer · Since at least Dec 29, 2022 |
| Mona Ashiya Other companies: Shattuck Labs, Inc. (Director · Since at least Aug 25, 2025); Sierra Oncology Inc (Director · Jun 8, 2021 – Jul 1, 2022 · Past) | Director · Since at least Dec 29, 2022 |
| Pamela Stephenson Other companies: Zynerba Pharmaceuticals Inc (Director · Jun 14, 2022 – Oct 10, 2023 · Past); Albireo Pharma Inc (Chief Commercial Officer · Apr 22, 2022 – Mar 2, 2023 · Past) | Chief Commercial Officer · Since at least Feb 26, 2024 |
| William Richard White Other companies: Akero Therapeutics Inc (Chief Financial Officer · Since at least Jun 10, 2025); Ventyx Biosciences Inc (Director · Since at least Jun 5, 2025) | Director · Since at least Jun 11, 2025 |
| Daniel Dubin Other companies: Pardes Biosciences Inc (Director · Feb 16, 2021 – Dec 23, 2021 · Past) | Director · Aug 11, 2020 – Aug 11, 2020 · Past |
| Dennis D Ryan Other companies: Pardes Biosciences Inc (Chief Financial Officer · Feb 16, 2021 – Feb 16, 2021 · Past) | Chief Financial Officer · Aug 11, 2020 – Aug 11, 2020 · Past |
| Joseph Beaulieu Other companies: Epizyme Inc (See Remarks · Aug 9, 2022 – Aug 12, 2022 · Past) | SVP, Finance · Since at least Nov 5, 2026 |
| Samuel B Barone Other companies: Adverum Biotechnologies Inc (SVP, Clinical Development · Jul 30, 2014 – Feb 9, 2017 · Past) | Chief Medical Officer · Apr 12, 2021 – Apr 12, 2021 · Past |
| Brian Richard MacDonald | Chief Innovation Officer · Dec 29, 2022 – Jun 28, 2023 · Past |
| Hua Yang | Chief Early Development Officer · Since at least Nov 5, 2026 |
| Jason Patrick Meyenburg | Chief Executive Officer, Director · Feb 5, 2021 – Jan 3, 2022 · Past |
| Jonathan Yu | Chief Operating Officer · Since at least Dec 29, 2022 |
| Lisa Amaya Price | Chief Human Resources Officer · Since at least Jan 12, 2026 |
| Marc Uknis | Chief Medical Officer · Feb 5, 2021 – Feb 5, 2021 · Past |
| Mark Chin | Director · Since at least Jun 11, 2025 |
| Melanie Chin | SVP, Clinical Development and Head of Medical Affairs · Since at least May 14, 2025 |
| Precillia Redmond | Chief People Officer · Feb 5, 2021 – Feb 23, 2021 · Past |
| Rahul Khara | Chief Legal Officer · Since at least Dec 29, 2022 |
| Rahul Rajan Kaushik | Chief Technical Officer · Since at least Nov 12, 2024 |
| Sonia Razzetti | SVP, Quality · Since at least Nov 5, 2026 |
| Srikanth Venkatraman | SVP, Head of Chemistry · Since at least Nov 5, 2026 |
| Steve Caffé | Chief Regulatory Officer · Since at least Nov 12, 2024 |
| William Jacob Savage | Chief Medical Officer · Since at least Dec 29, 2022 |
| Will Savage | Chief Medical Officer · Since at least Apr 15, 2026 |